Bioprocess Engineering in
Plasma-Derived Biopharmaceuticals
Nojin Biopharma, as a pioneer in the biological pharmaceutical industry, integrates Class A cleanroom quality control with advanced molecular separation technologies, committing to elevate the national capacity of human plasma-derived biopharmaceuticals.
The largest nominal blood plasma fractionation capacity in the country, powered by modern phase-separation technology.
Production of life-saving immunoglobulins, albumin, and coagulation factors relying on indigenous biotechnology.
Continuous development of purification processes in collaboration with national biopharma experts and medical doctors.
Implementation of advanced nanofiltration methods and multi-step pathogen inactivation.
Nojin Biological Products Portfolio
Scientific monographs, clinical data, and specifications of human plasma-derived biopharmaceuticals.
Albugin ® 20%
Solution for Infusion / محلول انفوزیون وریدی
Compensation and maintenance of plasma volume in shocks caused by hypovolemia, treatment of severe protein deficiency in patients with acute liver failure, nephrotic syndrome, acute and severe burns, and therapeutic plasma exchange.
اندیکاسیونهای بالینی
جبران و حفظ حجم پلاسما در شوکهای ناشی از هیپوولمی (Hypovolemia)، درمان کمبود شدید پروتئین در بیماران مبتلا به نارسایی حاد کبدی، سندرم نفروتیک، سوختگیهای حاد و شدید، و پلاسمافرزیس حجیم.
Immunogin ® 2500 mg
Solution for Infusion / محلول انفوزیون وریدی
Replacement therapy in primary immunodeficiency (PID) and secondary immunodeficiency (SID) syndromes. Immunomodulatory effect in acute immune thrombocytopenia (ITP), Guillain-Barré syndrome, Kawasaki disease, and chronic inflammatory demyelinating polyneuropathy (CIDP).
اندیکاسیونهای بالینی
درمان جایگزین در سندرمهای نقص ایمنی اولیه (PID) و ثانویه (SID). اثر تعدیلکننده سیستم ایمنی (Immunomodulatory) در ترومبوسیتوپنی ایمنی حاد (ITP)، سندرم گیلن باره، بیماری کاوازاکی، و پلینوروپاتی دمیلینزان التهابی مزمن (CIDP).
Core Values & Mission Statement
Relying on indigenous knowledge, continuous innovation, and compliance with the highest standards of safety and quality in manufacturing biological and pharmaceutical products.
.webp)
Knowledge-Based Innovation
Development of modern biotechnology processes relying on extensive R&D activities and localizing technical knowledge of strategic biological products in Iran.
Self-Sufficiency & National Independence
Reducing import reliance and enhancing national healthcare security through local plasma fractionation, aiming to fulfill the critical needs of patients.
World-Class Quality
Production of all biopharmaceuticals in strict compliance with GMP regulations and WHO quality guidelines to guarantee absolute biosafety for patients.
Latest Scientific Achievements
Localization of Advanced Plasma Fractionation Process; A Vital Step in the Country's Pharmaceutical Self-Sufficiency
Achieving technological independence in the human blood plasma fractionation chain is a strategic goal for the country in pharmaceutical biotechnology. In this scientific monograph, we review the achievements of Nojin's R&D in localizing advanced membrane separation methods.
Review of GMP Standard Requirements in Cold Chain Storage of Biological Products
Compliance with Good Manufacturing Practice (GMP) legal requirements in warehousing and distribution ensures the safety and efficacy of biological products.
Development of New Plasma-Derived Pharmaceutical Product Portfolio This Year
Nojin Biopharma's pharmaceutical portfolio is expanding with new clinical treatment options to maximize coverage of the country's therapeutic needs.
The Role of Nanotechnology in Enhancing the Stability of Injectable Biological Formulations
Injectable biological formulations are highly sensitive to environmental changes and shear forces. The use of nano-systems can improve the physicochemical stability of active proteins during storage.
Have a Question? Find the Answer with
Our Scientific Experts
In this section, we have endeavored to answer your frequently asked questions about the plasma fractionation process, GMP biosafety requirements, and strategic cold chain logistics in the most scientific manner.
Dr. Ali Mousavi
Director of Scientific Support & Biotechnology
Scientific Support Portal
تیم پشتیبانی علمی ما آماده پاسخگویی به سؤالات تخصصی فارماکودینامیک و میزان مصرف برای کلینیکها و بیمارستانها است.